We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
Topics Covered
- Clostridium difficile
- Resistance and spreading of Clostridium difficile
- Virulence factors
- Treatment and diagnosis
- Stop antibiotics
- Faecal transplants
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Fouch, S. (2025, January 30). Clostridium difficile [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved February 22, 2025, from https://doi.org/10.69645/DIHA9936.Export Citation (RIS)
Publication History
- Published on January 30, 2025
Financial Disclosures
- Dr. Sarah Fouch has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Introduction to Microbes
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, everyone. My name
is Dr. Sarah Fouch.
Within this session,
we will be considering
Clostridium difficile.
We will think about the
conditions that are
associated with
this organism and
the symptoms that a
patient may experience.
We will also think about
the virulence factors that
this organism expresses to
make it a successful pathogen.
0:26
Now, when we think about
Clostridium difficile,
we haven't known about this
organism for a long time.
It's been recognized for
its clinical importance
since the 1970s,
and it's the toxin that
Clostridium difficile
produces that is associated
with the symptoms that the
patient will experience.
But, again, by far a
key virulence factor
here is the fact that
it can form spores.
We will think about
these virulence
factors a little bit
more as we go through
this recording.
Now, when we think about
Clostridium difficile,
the toxin is a problem,
and it's particularly
a problem within
the hospital environment but
the spores are an even
bigger issue here.
If we think about
Clostridium difficile,
I want you to think about
antibiotics because this is
very much associated with
antibiotic-associated diarrhea.
We will talk about why
that is over the next
couple of slides.
A lot of us will carry
Clostridium difficile as part
of our normal bowel flora.
That's fine, it doesn't cause
us any issues whatsoever.
However, if you think about how
populated our
gastrointestinal tract is,
it has many different species
of organisms and they keep
each other in check so
one doesn't dominate
a certain area.
Now, when we have antibiotics,
obviously, that will
upset that balance.
We can also come
into contact with
Clostridium difficile as well.
Again, we can find it in
soil, water, and sewage.
We can also come
into contact with
it in the hospital
environment as well.